Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats
ISRN Nephrology · 2014
DOI: 10.1155/2014/479645 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Nephrology, 2014. Verfasst von Roya Rastghalam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran ; Department of Biology, Falavarjan Branch, Islam…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Isfahan University of Medical Sciences.
Abstract (Originalsprache)
Background
Cisplatin (CDDP) is an anticancer drug, which is accompanied with major side effects including nephrotoxicity. We tested two doses of losartan (10 and 20 mg/kg/day) against nephrotoxicity in a rat model treated with daily administration of CDDP (2.5 mg/kg/day).
Methods
Five groups of rats were examined. Groups 1 and 2 received losartan 10 and 20 mg/kg/day, i.p, for a period of 10 days. Group 3 received saline for 10 days, but from day 3 the animals received CDDP (2.5 mg/kg/day, i.p) for the next seven days. Groups 4 and 5 received treatment regimen the same as groups 1 and 2, but from day 3 they also received CDDP for the next seven days. At the end of the experiment, blood samples were obtained and the kidneys were removed to undergo pathological investigation and to obtain supernatant from homogenized tissue.
Results
CDDP induced nephrotoxicity, but the serum levels of creatinine and blood urea nitrogen were not attenuated by losartan. The pathological findings confirmed that losartan did not have nephroprotective effect in this experimental model.
Conclusion
According to the findings, losartan could not improve renal function impaired by toxicity induced by continuous doses of CDDP, and also it worsened the renal failure.
Autor:innen und Institutionen
- Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran ; Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan 84515, Iran.
- Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran ; Department of Physiology, Isfahan University of Medical Sciences, Isfahan 81745, Iran ; Isfahan MN Institute of Basic…
- Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan 84515, Iran.
- Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran.
- Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran ; Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan 81745, Iran.
- Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran ; Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan 81745, Iran.
Förderung
- Isfahan University of Medical Sciences
Zitieren
APA
Rastghalam, R., Nematbakhsh, M., Bahadorani, M., Eshraghi-Jazi, F., Talebi, A., Moeini, M., Ashrafi, F., & Shirdavani, S. (2014). Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats. ISRN Nephrology. https://doi.org/10.1155/2014/479645
Vancouver
Rastghalam R, Nematbakhsh M, Bahadorani M, Eshraghi-Jazi F, Talebi A, Moeini M, et al. Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats. ISRN Nephrology. 2014. doi:10.1155/2014/479645
BibTeX
@article{Rastghalam2014,
author = {Rastghalam, Roya and Nematbakhsh, Mehdi and Bahadorani, Mehrnoosh and Eshraghi-Jazi, Fatemeh and Talebi, Ardeshir and Moeini, Maryam and Ashrafi, Farzaneh and Shirdavani, Soheila},
title = {Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats},
journal = {ISRN Nephrology},
year = {2014},
doi = {10.1155/2014/479645}
}
EUVIMED